Medicated Punctured-Glove-Finger Spacer Study

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Sinusitis
Interventions
DRUG

Triamcinolone

Spacer will be impregnated with 2mL of Triamcinolone. The triamcinolone-impregnated spacer will be inserted into the middle meatal space after surgery. The spacer will be left in the middle meatus for a period of 6 days following surgery.

OTHER

Saline-impregnated spacer

Spacer will be impregnated with 2mL of Saline solution. The saline-impregnated spacer will be inserted into the middle meatal space intraoperatively. The spacer will be left in the middle meatus for a period of 6 days following surgery.

Trial Locations (1)

V6Z 1Y6

E.N.T. Clinic, St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

St. Paul's Hospital, Canada

OTHER

NCT01420471 - Medicated Punctured-Glove-Finger Spacer Study | Biotech Hunter | Biotech Hunter